Skip to content

Weight Management in Rural Communities

Weight Management in Rural Communities

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02932748
Acronym
M-DEx
Enrollment
187
Registered
2016-10-13
Start date
2017-01-31
Completion date
2021-10-31
Last updated
2024-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Weight Loss, Obesity, Body Weight

Brief summary

The goal of this study is to evaluate the effect of three weight management interventions (group phone conference calls, individual phone calls, and enhanced usual care) on weight across 18 months in overweight and obese adults recruited through and treated by rural primary care clinics.

Detailed description

The rates of overweight/obesity are significantly higher among residents of rural areas compared to their urban counterparts. Recent focus to provide whole-person health care suggests that rural primary care clinics may provide an ideal setting for delivery of weight management. This study is a 3 group randomized trial to evaluate intervention delivery. The investigators will randomize 200 overweight/obese adult residents of rural towns (town population \< 50,000) who obtain health care at primary care clinics to one of three groups for an 18 month trial (6 month weight loss; 12 month weight maintenance). Group 1) Group phone (GP)/Portion-Controlled Meals (PCM) Group 2) Individual phone (IP)/PCM Group 3) Enhanced usual care (EUC)/Conventional Diet (CD) All participants will receive a progressive physical activity program. Physical activity will progress from 45 min/wk in month 1 to 225 min/wk in month 4 and remain at 225 min/wk for the duration of the 18 month study for Group 1 & 2. Physical activity will progress from 45 min/wk in month 1 to 150 min/wk in month 4 and remain at 150 min/wk for the duration of the 18 month study for Group 3. Participants on the CD will be asked to consume a nutritionally balanced, reduced energy, high volume, lower fat (fat= 20-30% energy) diet recommended by the Academy of Nutrition and Dietetics and the USDA's MyPlate approach. Examples of meal plans consisting of suggested servings of proteins, grains, fruits and vegetables, dairy and fats based on individuals energy needs will be provided. Participants using PCM will consume PCMs with the addition of 5 fruits and vegetables per day during weight loss. EUC will meet with a health educator every 6 months to discuss weight management topics. GP & IP will receive the weight management intervention over the phone weekly during weight loss and biweekly during weight maintenance tracking diet and physical activity and will submit the results to a health educator prior to every meeting.

Interventions

DIETARY_SUPPLEMENTPortion Controlled Meals (PCM)

Portion controlled meals provide conveniently packaged, low-energy, high-nutritional content food.

BEHAVIORALGroup Phone (GP)

Weight management program delivered via group conference call.

DIETARY_SUPPLEMENTConventional Diet

Conventional diet (CD) will consist of a nutritionally balanced, reduced energy, high volume, lower fat (fat= 20-30% energy) diet based on USDA's MyPlate recommendations.

BEHAVIORALIndividual Phone (IP)

Weight management program delivered via individual phone call.

BEHAVIORALEnhanced Usual Care (EUC)

Weight management topics delivered face-to-face at clinic office every 6 months.

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
University of Kansas
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Body mass index 25 to 45 kg/m2 * Clearance from primary care physician

Exclusion criteria

* Unable to participate in moderate intensity physical activity * Participation in weight loss or physical activity program in previous 6 months * Greater than 3, 30-min bouts of planned exercise/week * Not weight stable (+/-4.6 kg) for 3 months prior to intake * Unwilling to be randomized to 1 of the 3 study groups * Report being pregnant during the previous 6 months or planned pregnancy in the following 18 months * Serious medical risk such as cancer, recent cardiac event * Current use of antipsychotics or untreated depression * Adherence to specialized diet regimens (food allergy, vegetarian, macrobiotic) * Binge eating disorder * Planning to movie to a location and no longer having access to rural clinic site

Design outcomes

Primary

MeasureTime frameDescription
Mean Weight Change Over 6 MonthsChange in baseline to 6 monthsMean weight change (kg) of participants between the three study groups.

Secondary

MeasureTime frameDescription
Change in BMI Across 6 MonthsChange from baseline to 6 monthsMean BMI change (kg/m\^2) of participants between the three study groups.
Change in Waist Circumference Across 6 MonthsChange from baseline - 6 monthsMean waist circumference change (cm) in the three study groups.
TriglyceridesChange from baseline to 6 monthsMean change in fasting triglycerides will be compared across all treatment arms.
Change in Fasting Glucose Across 6 MonthsChange from baseline to 6 monthsMean change in fasting glucose will be compared across all treatment arms.
Change in Systolic Blood Pressure Across 6 MonthsChange from baseline to 6 monthsMean change in systolic blood pressure will be compared across all treatment arms.
Cost Effectiveness at 6 Months6 monthsCost effectiveness was calculated for the group as the average total cost of the intervention arm (GP or IP) divided by the average weight loss at 6 months of the intervention arm. Costs associated with delivering the 6-month weight loss intervention, including supplies and intervention implementation, were estimated in 2019 U.S. dollars. Supply costs, i.e., pedometers, participant notebooks, providing and shipping low-calorie shakes and printed materials for the GP and IP arms. Implementation costs, i.e., time devoted to interventionist training, preparation and delivery of behavioral sessions and email contacts with participants were estimated as the time spent in these activities obtained from interventionist time sheets multiplied by interventionists hourly wage. Due to the cost effectiveness outcome measure being a ratio between two random variables, there are no dispersion/precision measures reported.
HDL-cholesterolChange from baseline to 6 monthsMean change in fasting HDL-cholesterol will be compared across all treatment arms.

Countries

United States

Participant flow

Participants by arm

ArmCount
Group Phone Conference Call
Delivery: Group Phone Diet: PCMs Portion Controlled Meals (PCM): Portion controlled meals provide conveniently packaged, low-energy, high-nutritional content food. Group Phone (GP): Weight management program delivered via group conference call.
71
Individual Phone Call
Delivery: Individual Phone Call Diet: PCMs Portion Controlled Meals (PCM): Portion controlled meals provide conveniently packaged, low-energy, high-nutritional content food. Individual Phone (IP): Weight management program delivered via individual phone call.
80
Enhanced Usual Care
Delivery: Face-to-Face Diet: Conventional Diet Conventional Diet: Conventional diet (CD) will consist of a nutritionally balanced, reduced energy, high volume, lower fat (fat= 20-30% energy) diet based on USDA's MyPlate recommendations. Enhanced Usual Care (EUC): Weight management topics delivered face-to-face at clinic office every 6 months.
36
Total187

Baseline characteristics

CharacteristicGroup Phone Conference CallIndividual Phone CallEnhanced Usual CareTotal
Age, Continuous50.3 years
STANDARD_DEVIATION 14.2
49.4 years
STANDARD_DEVIATION 11.2
50.4 years
STANDARD_DEVIATION 13.8
50.0 years
STANDARD_DEVIATION 12.9
Body Mass Index35.6 kg/m^2
STANDARD_DEVIATION 4.7
34.6 kg/m^2
STANDARD_DEVIATION 4.5
35.2 kg/m^2
STANDARD_DEVIATION 4.5
35.1 kg/m^2
STANDARD_DEVIATION 4.6
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants1 Participants0 Participants2 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
62 Participants70 Participants32 Participants164 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
8 Participants9 Participants4 Participants21 Participants
Region of Enrollment
United States
71 participants80 participants36 participants187 participants
Sex: Female, Male
Female
59 Participants66 Participants28 Participants153 Participants
Sex: Female, Male
Male
12 Participants14 Participants8 Participants34 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 710 / 800 / 36
other
Total, other adverse events
0 / 710 / 800 / 36
serious
Total, serious adverse events
0 / 711 / 801 / 36

Outcome results

Primary

Mean Weight Change Over 6 Months

Mean weight change (kg) of participants between the three study groups.

Time frame: Change in baseline to 6 months

ArmMeasureValue (MEAN)Dispersion
Group Phone Conference CallMean Weight Change Over 6 Months-11.4 kilogramsStandard Deviation 6.7
Individual Phone CallMean Weight Change Over 6 Months-9.1 kilogramsStandard Deviation 6.8
Enhanced Usual CareMean Weight Change Over 6 Months-2.6 kilogramsStandard Deviation 4.8
p-value: <0.0001ANOVA
Secondary

Change in BMI Across 6 Months

Mean BMI change (kg/m\^2) of participants between the three study groups.

Time frame: Change from baseline to 6 months

ArmMeasureValue (MEAN)Dispersion
Group Phone Conference CallChange in BMI Across 6 Months-4.1 kg/m^2Standard Deviation 2.2
Individual Phone CallChange in BMI Across 6 Months-3.2 kg/m^2Standard Deviation 2.3
Enhanced Usual CareChange in BMI Across 6 Months-0.9 kg/m^2Standard Deviation 1.6
Secondary

Change in Fasting Glucose Across 6 Months

Mean change in fasting glucose will be compared across all treatment arms.

Time frame: Change from baseline to 6 months

Population: Blood values were missing for n=2 in GP, n=7 in IP and n=2 in EUC.

ArmMeasureValue (MEAN)Dispersion
Group Phone Conference CallChange in Fasting Glucose Across 6 Months-5.9 mg/dLStandard Deviation 9.7
Individual Phone CallChange in Fasting Glucose Across 6 Months-4.4 mg/dLStandard Deviation 26.2
Enhanced Usual CareChange in Fasting Glucose Across 6 Months1.6 mg/dLStandard Deviation 8.3
Secondary

Change in Systolic Blood Pressure Across 6 Months

Mean change in systolic blood pressure will be compared across all treatment arms.

Time frame: Change from baseline to 6 months

ArmMeasureValue (MEAN)Dispersion
Group Phone Conference CallChange in Systolic Blood Pressure Across 6 Months-8.6 mmHgStandard Deviation 13.1
Individual Phone CallChange in Systolic Blood Pressure Across 6 Months-7.9 mmHgStandard Deviation 13.4
Enhanced Usual CareChange in Systolic Blood Pressure Across 6 Months1.7 mmHgStandard Deviation 19.5
Secondary

Change in Waist Circumference Across 6 Months

Mean waist circumference change (cm) in the three study groups.

Time frame: Change from baseline - 6 months

ArmMeasureValue (MEAN)Dispersion
Group Phone Conference CallChange in Waist Circumference Across 6 Months-7.2 cmStandard Deviation 6.1
Individual Phone CallChange in Waist Circumference Across 6 Months-6.1 cmStandard Deviation 5.8
Enhanced Usual CareChange in Waist Circumference Across 6 Months-2.1 cmStandard Deviation 4.5
Secondary

Cost Effectiveness at 6 Months

Cost effectiveness was calculated for the group as the average total cost of the intervention arm (GP or IP) divided by the average weight loss at 6 months of the intervention arm. Costs associated with delivering the 6-month weight loss intervention, including supplies and intervention implementation, were estimated in 2019 U.S. dollars. Supply costs, i.e., pedometers, participant notebooks, providing and shipping low-calorie shakes and printed materials for the GP and IP arms. Implementation costs, i.e., time devoted to interventionist training, preparation and delivery of behavioral sessions and email contacts with participants were estimated as the time spent in these activities obtained from interventionist time sheets multiplied by interventionists hourly wage. Due to the cost effectiveness outcome measure being a ratio between two random variables, there are no dispersion/precision measures reported.

Time frame: 6 months

Population: Data not collected for the Enhanced Usual Care Arm/Group as this was the comparator.

ArmMeasureValue (NUMBER)
Group Phone Conference CallCost Effectiveness at 6 Months60 $/kg
Individual Phone CallCost Effectiveness at 6 Months93 $/kg
Secondary

HDL-cholesterol

Mean change in fasting HDL-cholesterol will be compared across all treatment arms.

Time frame: Change from baseline to 6 months

Population: Blood values were missing for n=2 in GP, n=7 in IP and n=2 in EUC.

ArmMeasureValue (MEAN)Dispersion
Group Phone Conference CallHDL-cholesterol0.3 mg/dLStandard Deviation 9.6
Individual Phone CallHDL-cholesterol0.3 mg/dLStandard Deviation 9.6
Enhanced Usual CareHDL-cholesterol1.6 mg/dLStandard Deviation 6.2
Secondary

Triglycerides

Mean change in fasting triglycerides will be compared across all treatment arms.

Time frame: Change from baseline to 6 months

Population: Blood values were missing for n=2 in GP, n=7 in IP and n=2 in EUC.

ArmMeasureValue (MEAN)Dispersion
Group Phone Conference CallTriglycerides-26.2 mg/dLStandard Deviation 39
Individual Phone CallTriglycerides-29.4 mg/dLStandard Deviation 61.3
Enhanced Usual CareTriglycerides4.8 mg/dLStandard Deviation 39.1

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026